| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |